Stay updated on Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.3.1 was removed, updating the page's revision label without altering study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:52:57.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The Publications section now includes clarifications that publications are provided voluntarily and are auto-filled from PubMed, and shows a Revision: v3.3.1 tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-24T14:43:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Deletion of the government funding lapse notice from the page; core study content, eligibility criteria, and results remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:57:33.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the study details page; the content and structure appear unchanged. Core sections such as Study Overview, Eligibility Criteria, Interventions, and Outcomes remain as in the previous version.
    Difference
    0.4%
    Check dated 2025-11-03T01:21:05.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Major update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:23:49.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page update adds a new version tag (v3.1.0) and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision tag (v3.0.2), indicating a cleanup of outdated topics rather than adding new core content.
    Difference
    0.4%
    Check dated 2025-09-28T03:20:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.